L-FABP, natriuretic peptide and cardiac troponin in individuals in need of cardiac therapy

• 收藏
• 分享

专利权人:

エフ．ホフマン－ラ;アーゲー;ロシュ;エフ.ホフマン-ラ ロシュ アーゲー

发明人:

ヘス，ゲオルク,ホルシュ，アンドレア,ズドゥネク，ディートマル,ヘス,ゲオルク,ホルシュ,アンドレア,ズドゥネク,ディートマル

申请号：

JP2011509975

公开号：

JP5419968B2

申请日:

2009.05.20

申请国别(地区):

JP

年份:

2014

代理人:

摘要：

Disclosed is a method for identifying a subject being susceptible to a cardiac therapy, comprising (a) determining the amounts of liver fatty acid binding protein, and at least one further polypeptide from the group of a cardiac troponin and a natriuretic peptide in at least one sample of a subject suffering from heart failure, (b) comparing the thus determined amounts to suitable reference amounts, and (c) identifying a subject being susceptible to a cardiac therapy. Also described is a device and a kit adapted to carry out the method of the present invention. Also described is the use of liver fatty acid binding protein and at least one further polypeptide from the group of a cardiac troponin and a natriuretic peptide for identifying a subject being susceptible to a cardiac therapy.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/